This work highlights the use of bicyclic heterocyclic compounds as monoacylglycerol lipase inhibitors potentially in the treatment of Alzheimer's disease, Parkinson's disease, ALS, traumatic brain injury, and multiple sclerosis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10788934 | PMC |
http://dx.doi.org/10.1021/acsmedchemlett.3c00548 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!